U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...

Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Lilly announced several changes to its executive leadership team. 1 These changes are mostly related to the company’s ...

USPS said its controllable loss was $848 million, up from $317 million in the same quarter last year as mail volume continues ...

Eli Lilly (NYSE:LLY) recently announced leadership transitions, including new roles for Ilya Yuffa, Patrik Jonsson, and ...

Eli Lilly announced a strategic executive shuffle aimed at boosting its U.S. and global operations, especially in ...

Eli Lilly and Co. on Thursday announced three executive leadership transitions that the Indianapolis drugmaker said better ...